Global Balloon Angioplasty Market Size, Share, Growth Analysis Report - Forecast 2034

Global Balloon Angioplasty Market: Industry Perspective

The global balloon angioplasty market size was worth around USD 3.53 Billion in 2024 and is predicted to grow to around USD 7.13 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 7.3% between 2025 and 2034. The report analyzes the global balloon angioplasty market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the balloon angioplasty industry.

Request Free Sample

Global Balloon Angioplasty Market: Overview

Balloon angioplasty is a specially devised catheter with tiny balloons in a carefully guided artery to the blockage. It is then inflated for widening the opening of the artery and then increases the flow of blood to the heart. Afterward, the stent is placed in the artery at the time of this procedure for keeping the artery open. Then the balloon is shrunk and then removed from the artery. Precisely, balloon angioplasty is a kind of minimally invasive cardiac catheterization method that is utilized for opening narrow or blocked arteries.

Global Balloon Angioplasty Market: Growth Drivers

The balloon angioplasty market is primarily driven by the increasing prevalence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, which continue to be leading causes of morbidity and mortality worldwide. Growing awareness about minimally invasive procedures, combined with patient preference for faster recovery and reduced hospital stays, boosts the adoption of balloon angioplasty. Technological advancements, such as drug-coated balloons that help reduce restenosis rates, further propel market growth. Additionally, the rising geriatric population, who are more susceptible to vascular diseases, and the expanding healthcare infrastructure in emerging economies contribute significantly to the market’s upward trajectory.

Restraints:

Despite its benefits, the balloon angioplasty market faces several restraints, including the risk of complications such as vessel dissection, restenosis, or thrombosis, which can deter patient and physician confidence in the procedure. High costs associated with advanced devices and procedures can limit access, especially in low- and middle-income regions. Furthermore, reimbursement challenges and regulatory hurdles for new product approvals add complexity and delay market entry for innovative solutions. The presence of alternative treatment options, such as coronary artery bypass grafting (CABG) and stenting, also creates competitive pressure that may restrain market growth.

Opportunities:

Emerging markets present substantial opportunities for the balloon angioplasty market due to increasing investments in healthcare infrastructure and growing patient awareness about cardiovascular interventions. Innovations in balloon technology, such as bioresorbable balloons and those designed for complex lesions, open new avenues for market players. Rising focus on personalized medicine and precision healthcare provides opportunities to tailor angioplasty solutions to individual patient needs. Moreover, collaborations between medical device companies and healthcare providers for research and development can accelerate innovation and expand market reach, particularly in addressing unmet clinical needs.

Challenges:

The balloon angioplasty market faces challenges such as intense competition among established players and the constant need for technological differentiation to maintain market share. Training and skill requirements for healthcare professionals performing angioplasty procedures can be a barrier, particularly in regions with limited resources. Economic uncertainties and budget constraints in hospitals may lead to deferred purchases of new or advanced balloon angioplasty devices. Additionally, ongoing clinical scrutiny regarding long-term outcomes and safety of drug-coated balloons or novel technologies poses challenges for widespread adoption, necessitating continuous clinical validation and evidence generation.

Key Insights

• As per the analysis shared by our research analyst, the global balloon angioplasty market is estimated to grow annually at a CAGR of around 7.3% over the forecast period (2025-2034).
• Regarding revenue, the global balloon angioplasty market size was valued at around USD 3.53 Billion in 2024 and is projected to reach USD 7.13 Billion by 2034.
• The balloon angioplasty market is projected to grow at a significant rate due to growing aging population, increasing prevalence of cardiovascular diseases, advancements in balloon catheter technologies including drug-eluting balloons, and the rising preference for minimally invasive procedures.
• Based on Product, the Normal Balloons segment is expected to lead the global market.
• On the basis of Application, the Peripheral Vascular Disease segment is growing at a high rate and will continue to dominate the global market.
• Based on the End-use, the Ambulatory Surgical Centers segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Global Balloon Angioplasty Market Report Scope:

Global Balloon Angioplasty Market: Segmentation Analysis

The global balloon angioplasty market is segmented based on Product, Application, End-use, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2025 to 2034.

Based on Product, the global balloon angioplasty market is divided into Normal Balloons, Drug Coated Balloons, Cutting Balloons, Scoring Balloons.

On the basis of Application, the global balloon angioplasty market is bifurcated into Peripheral Vascular Disease, Coronary Vascular Disease.

By End-use, the global balloon angioplasty market is split into Ambulatory Surgical Centers, Hospitals, Cath Labs.

The Regional, this segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America,and the Middle East and Africa.

Global Balloon Angioplasty Market: Regional Insights

The balloon angioplasty market exhibits strong regional dynamics, with North America leading due to a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant adoption of minimally invasive procedures. Europe follows closely, driven by rising geriatric populations and increasing healthcare expenditures, while regulatory support for innovative medical devices boosts market penetration. The Asia-Pacific region is poised for the fastest growth, fueled by growing awareness of cardiovascular health, expanding healthcare access, and increasing procedural volumes in countries like China and India. Meanwhile, regions such as Latin America and the Middle East & Africa are experiencing steady growth, supported by improving medical facilities and rising incidences of coronary artery diseases, although market expansion remains somewhat limited by economic constraints and lower healthcare spending.

Global Balloon Angioplasty Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the balloon angioplasty market on a global and regional basis.

The global balloon angioplasty market is dominated by players like:

• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson Services Inc.
• Abbott
• C. R. Bard Inc.
• Spectranetics
• Terumo Medical Corporation
• Cardinal Health
• BIOTRONIK
• Cook Medical
• ENDOCOR GmbH
• B. Braun SE

Global Balloon Angioplasty Market: Segmentation Analysis

The global balloon angioplasty market is segmented as follows;

By Product

• Normal Balloons
• Drug Coated Balloons
• Cutting Balloons
• Scoring Balloons

By Application

• Peripheral Vascular Disease
• Coronary Vascular Disease

By End-use

• Ambulatory Surgical Centers
• Hospitals
• Cath Labs

Global Balloon Angioplasty Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America